Warby Parker's Q2 2025 Earnings: A Mixed Bag with Long-Term Growth Potential

Warby Parker's Q2 2025 earnings report delivered a classic case of “mixed bag” for investors: strong revenue growth and margin improvements offset by a GAAP net loss and gross margin contraction. Yet, beneath the numbers lies a compelling story of operational resilience, strategic innovation, and long-term positioning in a $68 billion U.S. eyewear market. For investors, the question is whether the stock's current valuation—trading at a 31.9x EBITDA multiple and a negative P/E ratio—justifies its long-term potential.

Operational Strength: Revenue Growth and EBITDA Beat

Warby Parker's Q2 2025 net revenue of $214.5 million, up 13.9% year-over-year, exceeded analyst estimates and underscored the company's ability to scale. This growth was driven by a 9.0% increase in active customers (2.60 million trailing 12-month customers) and a 4.6% rise in average revenue per customer to $316. The latter reflects a shift toward higher-margin products like premium frames and contact lenses, which now account for a growing share of sales.

Adjusted EBITDA of $25.0 million for the quarter—a $5.4 million year-over-year increase—was a standout, with a margin of 11.7% (up 130 basis points). This improvement, despite a GAAP net loss of $1.8 million, highlights the company's ability to leverage its expense base as revenue scales. Selling, general, and administrative (SG&A) expenses fell to 55.1% of revenue from 60.8% in the prior year, driven by lower stock-based compensation and corporate costs.

Margin Pressures and Strategic Trade-Offs

The 53.0% gross margin in Q2 2025, down from 56.0% in the prior year, was a drag. This decline stemmed from $2.5 million in inventory write-downs tied to the discontinuation of the Home-Try On program, as well as higher costs for contact lenses, store occupancy, and tariffs. While these one-time and structural pressures are concerning, they reflect strategic decisions to streamline operations and expand into higher-growth segments. For example, contact lens sales now contribute meaningfully to revenue, albeit with lower gross margins than eyewear.

Warby Parker's management acknowledged these challenges but emphasized their commitment to balancing margin preservation with customer experience. Selective price increases and a shift in product mix toward premium offerings are expected to offset some of the margin drag over time.

Market Expansion and Innovation: The Long Game

The company's store expansion strategy remains a cornerstone of its growth. Warby Parker opened 11 new stores in Q2 2025, bringing its total to 298, and plans to open 45 stores in 2025, including five shop-in-shops at Target. These physical locations not only drive direct sales but also reinforce brand visibility in a sector dominated by big-box retailers and online competitors.

Innovation is another key pillar. The launch of “Advisor,” an AI-driven personalized recommendation tool, and a partnership with Google to develop intelligent eyewear signal Warby Parker's ambition to lead in tech-integrated fashion. These initiatives align with broader consumer trends toward personalization and wearable technology, positioning the company to capture value beyond traditional eyewear.

Valuation: A Premium for Growth or a Bubble?

Warby Parker's valuation remains a point of contention. As of August 8, 2025, the stock trades at a 31.9x EBITDA multiple and a negative P/E ratio of -1,433.9x, reflecting its unprofitable GAAP net income. By comparison, industry peers like EssilorLuxottica trade at 18.2x EBITDA and 46.4x P/E, suggesting Warby Parker is priced at a premium. However, this premium is justified by its growth trajectory:

• Revenue CAGR: 14–15% for 2025, with a full-year guidance of $880–888 million.
• EBITDA Margin Expansion: From 10% LTM to a projected 11.1–11.4% for 2025.
• Free Cash Flow: $23.9 million in Q2 2025, with a $286.4 million cash balance providing flexibility for reinvestment.

Analysts' price targets ($16–$30) reflect a wide range of expectations, but the stock's 72.83% one-year return and 10.37% pre-market surge post-earnings suggest investor confidence in its long-term story.

Investment Thesis: Undervalued or Overhyped?

Warby Parker's Q2 results highlight a company in transition: profitable on an EBITDA basis but not yet on a GAAP net income basis. The gross margin contraction and short-term losses are temporary headwinds, not existential threats. The company's strong balance sheet, disciplined cost management, and strategic investments in AI and retail expansion provide a clear path to profitability.

For long-term investors, the key question is whether the market is overcorrecting for short-term margin pressures. Given Warby Parker's brand strength, customer loyalty, and disruptive positioning in a fragmented market, the stock appears undervalued relative to its growth potential. The 31.9x EBITDA multiple, while high, is justified by its 14–15% revenue growth and improving margins.

Recommendation: Buy for investors with a 3–5 year horizon. The stock is likely to re-rate as EBITDA margins stabilize and the company transitions to GAAP profitability.

In conclusion, Warby Parker's Q2 2025 earnings may look mixed on paper, but they tell a story of a company executing its long-term vision with discipline and innovation. For those willing to look beyond short-term profit disappointments, the stock offers a compelling opportunity to invest in a brand that's reshaping the eyewear industry.
"""